Answers are grounded in this paper and cite their sources.
Poorly soluble small molecules typically pose translational hurdles owing to their low solubility, low bioavailability, and formulation challenges. Nanocrystallization is a versatile method for salvaging poorly soluble drugs with the added benefit of a carrier-free delivery system. In this review, we provide a comprehensive analysis of nanocrystals with emphasis on their clinical translation. Additionally, the review sheds light on clinically approved nanocrystal drug products as well as those in development.
No takes yet. Share an insight, caveat, or question.
Jarvis et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: